Barclays: Teva’s reshuffle hits morale, Levin remains popular
Barclays says that Jeremy Levin remained popular with Teva’s rank-and-file and this will be destabilizing to morale.
By YOSSI NISSAN/GLOBES
Published: NOVEMBER 4, 2013 02:59
Advertisement
1
var articleID = window.location.pathname.substring( window.location.pathname.lastIndexOf("-")+1);
var articlesWithoutLinkPremium = ["661248", "661185", "661893", "665206", "602479"];
if( articlesWithoutLinkPremium.includes(articleID) == true)
{
document.getElementById("premium-link").style.display = "none";
}
var cont = `Sign up for The Jerusalem Post Premium Plus for just $5 Upgrade your reading experience with an ad-free environment and exclusive content
